Breast Cancer
Conference Coverage
Abemaciclib cuts early recurrence in high-risk breast cancer
Abemaciclib improved invasive disease-free survival when added to endocrine therapy.
Conference Coverage
First-in-class ADC ups survival in mTNBC
Sacituzumab govitecan prolonged progression-free and overall survival.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Latest News
AI algorithm on par with radiologists as mammogram reader
Combining the algorithm with first-reader radiologists revealed more breast cancer cases than combining first- and second-reader radiologists.
From the Journals
Study supports multigene panel testing for all breast cancer patients with second primary cancers
The results could lead to better implementation of cancer prevention and screening strategies, according to researchers.
News from the FDA/CDC
Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results
Negative results from the IMpassion131 trial may jeopardize the U.S. approval of atezolizumab in breast cancer.
From the Journals
Hair dye and cancer study ‘offers some reassurance’
Chronicles of Cancer
Chronicles of Cancer: A history of mammography, part 2
The history of mammography is rife with controversy, enmeshed in the War on Cancer, corporate and professional interests, and the women’s rights...
Conference Coverage
VTE, sepsis risk increased among COVID-19 patients with cancer
Cancer patients had significantly lower hemoglobin levels, platelet counts, and red and white blood cell counts.
Guidelines
First guideline on NGS testing in cancer, from ESMO
From the Journals
Immunotherapy should not be withheld because of sex, age, or PS